Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8784988 | Advances in Radiation Oncology | 2017 | 8 Pages |
Abstract
This small series suggests that aggressive re-RT of inoperable and symptomatic GU malignancies that is undertaken with meticulous treatment planning is well tolerated and provides excellent, durable relief without undue short-term toxicity. Validation in a larger prospective cohort is required.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sophia C. MD, Lauren C. MD, Mandar S. PhD, Vinayak MD, MSc, Paul L. MD, Neil E. MD, MPH, Stephanie BA, Sarah MPH, Akila N. MD, MPH, Jason A. MD, DPhil, Clair J. MD,